Choose Your language:
- Testimonials
-
great service thanks
- andrew
Read more »
- Articles
Our billing is certified by:
- News
-
- What’s best at beating swine flu, soap or gel?
- Commuters obsessively scrub their hands with gel
- Swine flu drug treatment will replace containment strategy
- More than 150 people have been diagnosed with swine flu over the past 24 hours as the rate of infection accelerates, pushing the total number of UK cases above 1,000
- Is the flu jab a waste of time?
- On balance, probably not
- Global flu pandemic would probably kill 62m, study says
- Around 62 million people in the world are likely to die if there is a flu pandemic and more than 70,000 of those deaths will be in the UK, according to a statistical analysis published today
- Vaccine against lethal strain of avian flu ready for human testing
- A British drug company is seeking permission to conduct the first human trials of an experimental vaccine against the avian flu virus
-
- Antiviral research and Neutron Star System behaviours earn BC students ... - Canada NewsWire (press release)
- Antiviral research and Neutron Star System behaviours earn BC students
- Broad-Spectrum Antivirals: The Future of HIV Treatment? - TheBody.com
- Broad-Spectrum Antivirals: The Future of HIV Treatment?TheBody
- The Global Antivirals Market Expected To Reach $30 Billion By 2017 - OfficialWire (press release)
- The Global Antivirals Market Expected To Reach $30 Billion By 2017OfficialWire (press release)by Press Office In 2010, the global antivirals market was estimated to be worth $22
- New Antivirals Show Poor Safety in HCV With Cirrhosis - Medscape
- New Antivirals Show Poor Safety in HCV With CirrhosisMedscapeMay 2, 2012 (Barcelona, Spain) — Two relatively new direct-acting antiviral drugs have poor safety profiles in patients with hepatitis C virus (HCV) and cirrhosis, including a high rate of serious adverse events leading to study discontinuation
- deadly pandemic a matter of when, not if - Sydney Morning Herald
- deadly pandemic a matter of when, not ifSydney Morning HeraldThe drugs that would help are the antivirals, such as Relenza and Tamiflu
